Pfizer welcomes the public to join webcast of healthcare conference discussion

Pfizer, a renowned biopharmaceutical company with a long-standing commitment to innovation and excellence, recently announced an upcoming webcast discussion featuring Albert Bourla, the Chairman and Chief Executive Officer. This event is part of the TD Cowen 46th Annual Health Care Conference and is scheduled for Monday, March 2, 2026, at 10:30 a.m. EST.

Investors, stakeholders, and interested members of the public are invited to tune in to the webcast to gain valuable insights into Pfizer’s latest developments and future objectives. Accessing the webcast is simple – visit Pfizer’s official website at www.pfizer.com/investors to listen live. Details regarding registration and access to the webcast will be provided on the website, ensuring a seamless experience for all participants.

Following the conclusion of the live discussion, a transcript and webcast replay will be made available on Pfizer’s website within 24 hours, allowing those unable to attend the event to catch up on the key points discussed. This content will remain accessible for at least 90 days, ensuring a wider audience can benefit from the information shared during the webcast.

Pfizer’s overarching goal is to transform the lives of patients worldwide by harnessing the power of science and leveraging its extensive global resources. By developing cutting-edge therapies and innovative medicines, Pfizer aims to raise the bar for quality, safety, and value in the healthcare sector. Dedicated Pfizer professionals across different markets strive every day to push the boundaries of wellness, prevention, treatment, and cure for some of the most challenging diseases of our time.

As a responsible industry leader, Pfizer actively collaborates with healthcare providers, governments, and local communities to enhance access to quality healthcare services globally. With a legacy spanning 175 years, Pfizer has remained committed to making a meaningful difference in the lives of those who depend on their products and services. Regular updates and relevant information for investors are posted on Pfizer’s official website, showcasing the company’s transparent and open communication with its stakeholders.

During the webcast, Pfizer may share forward-looking statements related to various aspects of its business, including financial performance, product pipeline, market dynamics, regulatory considerations, and COVID-19 impact assessments. While these statements provide insight into Pfizer’s strategic direction, they are subject to inherent risks and uncertainties that could differ from actual outcomes. Pfizer’s commitment to updating these statements reflects its dedication to transparency and accountability in its operations.

In conclusion, Pfizer’s webcast discussion featuring Albert Bourla promises to be an insightful event for investors and the public alike. By sharing its latest developments, strategic direction, and future prospects, Pfizer continues to demonstrate its commitment to driving positive change and innovation in the healthcare industry.